english.prescrire.org > Spotlight > 100 most recent

Spotlight

Every month, the subjects in Prescrire’s Spotlight.

100 most recent :  1 | 10 | 20 | 30 | 40 | 50 | 60 | 70 | 80 | 90

In the December issue of Prescrire International - Teriparatide (Forsteo° and other brands) in pen injectors or cartridges: multidose formulations which must not be drawn into a syringe

FREE DOWNLOAD Drawing the contents of a cartridge or prefilled pen into a syringe carries a risk of dosing errors.
Full text available for free download.
1 December 2021

Full value

 Editorial  Packaging is a key determinant of a medicinal product's quality. It is high time that pharmaceutical companies and drug regulatory agencies appreciated the full value of high-quality drug packaging.
1 December 2021

The newly redesigned Prescrire International, from January 2022!

 COMING SOON  From January 2022, the new, redesigned Prescrire International casts a critical eye on new drugs authorised in Europe. Don't miss out!
1 December 2021

Hypoglycaemia with loss of consciousness in insulin-treated patients: a treatment that is easier to administer

When a patient with insulin-treated diabetes has lost consciousness due to hypoglycaemia, glucagon is the drug of choice. It is now available as a nasal spray (Baqsimi°), making it easier for the patient’s family or friends to manage severe hypoglycaemia.
1 December 2021

Haemorrhaging after childbirth: medicines are sometimes responsible

Towards the end of pregnancy, the medicines the woman is taking, including serotonergic antidepressants (SSRIs and SNRIs), should be reviewed and sometimes adjusted, because some drugs can cause or worsen potentially fatal haemorrhages.
1 December 2021

France's Mediator° trial reveals a cosy relationship between representatives of the French drug regulatory agency and an influential company

1 December 2021

Known adverse effects of messenger RNA covid-19 vaccines
as of mid-2021

FEATURED REVIEW With several hundred million people worldwide now vaccinated with an mRNA vaccine, surveillance conducted by various pharmacovigilance teams has identified a few signals of very rare adverse effects, notably pericarditis and myocarditis.
Full review (2 pages) available for download by subscribers.
1 November 2021

In the November issue of Prescrire International: adverse effects of growth hormone and of thiazide diuretics

FREE DOWNLOAD In the "Adverse effects" section this month, Prescrire reports on the cardiovascular effects of growth hormone, and on ocular adverse effects of thiazide diuretics.
Full text available for free download.
1 November 2021

Words and numbers

 Editorial  Evidence-based medicine is more than just numbers reported in randomised trials or meta-analyses. In some cases, the best evidence is to be found in qualitative data.
1 November 2021

Asthma and COPD: don't confuse the brand name of the drug with the brand name of the inhaler

Some drugs for asthma or chronic obstructive pulmonary disease (COPD) are supplied with an inhaler device which has its own brand name. It is important to distinguish clearly between the name of the drug and the name of the inhaler.
1 November 2021

1 | 10 | 20 | 30 | 40 | 50 | 60 | 70 | 80 | 90